| Q40396910 | Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus |
| Q35093882 | Bone mineral density in patients with end-stage renal disease and its evolution after kidney transplantation |
| Q38514444 | Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation. |
| Q50930225 | Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. |
| Q53613798 | Effects of cyclosporin-A-induced immunosuppression on periapical lesions in rats. |
| Q57194218 | Long-term outcomes in pediatric renal transplant recipients who survive into adulthood |
| Q79290594 | Skeletal Disproportion in Children with Chronic Renal Disease |
| Q41858729 | Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant Staphylococcus aureus in a renal transplant recipient with Fabry-Anderson disease |
| Q44053021 | The prevalence of osteopenia in pediatric renal allograft recipients varies with the method of analysis |
| Q74436822 | [Physiologic basis: regulation of bone remodeling] |